1 -Adrenoceptor subtypes and effect of 1A -adrenoceptor agonist NS-49 on guinea pig nasal mucosa vasculature

By Tanimitsu N.   Yajin K.   Sasa M.   Tsuru H.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite

Effects of 1 -adrenoceptor antagonists on agonist and tilt-induced changes in blood pressure: relationships to uroselectivity

By Hieble J.P.   Kolpak D.C.   McCafferty G.P.   Ruffolo R.R.   Testa R.   Leonardi A.  

European Journal of Pharmacology, Vol. 373, Iss. 1, 1999-05 ,pp. : 51-62

Elsevier

Access to resources Recommend Favorite

Antagonism of 1 -adrenoceptor agonist-induced responses by rilmenidine in vascular smooth muscle

By Cario-Toumaniantz C.   Loirand G.   Pacaud P.  

European Journal of Pharmacology, Vol. 341, Iss. 2, 1998-01 ,pp. : 179-185

Elsevier

Access to resources Recommend Favorite

Modulation of 1B -adrenoceptor expression by agonist and protein kinase inhibitors

By Bird K.S.   Anderson J.L.   Toews M.L.  

European Journal of Pharmacology, Vol. 340, Iss. 2, 1997-12 ,pp. : 267-275

Elsevier

Access to resources Recommend Favorite

Correction of neurovascular deficits in diabetic rats by 2 -adrenoceptor agonist and 1 -adrenoceptor antagonist treatment: Interactions with the nitric oxide system

By Cotter M.A.   Cameron N.E.  

European Journal of Pharmacology, Vol. 343, Iss. 2, 1998-02 ,pp. : 217-223

Elsevier

Access to resources Recommend Favorite